CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 30 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,460,000 | -80.8% | 400,000 | -66.7% | 0.16% | -83.1% |
| Q2 2018 | $12,828,000 | -36.4% | 1,200,000 | -36.2% | 0.95% | -36.9% |
| Q1 2018 | $20,182,000 | +48.5% | 1,880,880 | -3.1% | 1.50% | +5.8% |
| Q4 2017 | $13,586,000 | -19.9% | 1,940,880 | 0.0% | 1.42% | -52.5% |
| Q3 2017 | $16,963,000 | -4.1% | 1,940,880 | 0.0% | 3.00% | +2.2% |
| Q2 2017 | $17,681,000 | +14.7% | 1,940,880 | 0.0% | 2.93% | +31.0% |
| Q1 2017 | $15,411,000 | -26.1% | 1,940,880 | -16.8% | 2.24% | -20.4% |
| Q4 2016 | $20,860,000 | -39.5% | 2,333,333 | +17.4% | 2.81% | -26.1% |
| Q3 2016 | $34,496,000 | +147.5% | 1,988,208 | 0.0% | 3.80% | +92.5% |
| Q2 2016 | $13,937,000 | – | 1,988,208 | – | 1.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |